The objective of this study was to investigate the prevalence of obesity and its relationship with adverse outcomes in ICU cardiothoracic patients. We performed a retrospective analysis of cardiothoracic patients admitted to The Royal Melbourne Hospital ICU between 2002 and 2014. Eight thousand and sixty-four patients who underwent coronary artery bypass, valve replacement/repair, or both, were divided into six categories of body mass index using World Health Organization criteria. Prevalence of obesity over time in the ICU was measured and compared to prevalence of obesity in the adult Australian population. The association between obesity and adverse postoperative outcomes was then analysed. Obesity is currently 1.2 times more prevalent in the Royal Melbourne Hospital ICU cardiothoracic patients than in the adult Australian population, with 33.5% of patients having a body mass index ≥30 kg/m 2 . Over time, this was relatively constant, but an increasing proportion were morbidly obese. Obesity, but not morbid obesity, was associated with reduced 30-day mortality (odds ratio [OR] 0.41). Both obese and morbidly obese patients had reduced odds of return to theatre for bleeding (OR 0.49 and OR 0.19, respectively), but increased odds of new-onset renal failure (OR 1.62 and OR 3.17, respectively). Morbidly obese patients had double the odds of an ICU stay longer than 14 days (OR 2.05). In summary, a growing proportion of our obese ICU patients are morbidly obese, with a dramatically increased length of ICU stay. This has major implications for resource allocation in the ICU, and may inform modelling of future bed utilisation. Obesity, but not morbid obesity, conferred a mortality benefit.
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Obesity is a growing pandemic, almost tripling between 1995 and 2011 to 27.2% in Australia 1 , and projected to affect one in three adults by 2025 2 . Correspondingly, ICUs appear to be treating more obese patients 3 . In a 2007 Australian study of cardiothoracic patients, obesity was 1.4 times more prevalent than in the general adult Australian population (30.4% versus 21.2%) 4 . This higher prevalence is consistent with results from ICU studies across all admission types in the UK, Europe and the US [5] [6] [7] .
A number of epidemiological studies have found obesity is associated with increased all-cause mortality 8, 9 and obesity has historically been associated with poor outcomes after cardiothoracic surgery 10 . In contrast, recent studies have suggested better outcomes following cardiothoracic surgery in obese patients [11] [12] [13] , found no effect [14] [15] [16] , or have shown a greater incidence of postoperative complications [3] [4] [5] 17, 18 .
It is reasonable to postulate that variability in study findings is secondary to inconsistencies in outcome definitions.
Many authors have not compared outcomes based on standard World Health Organization (WHO) body mass index (BMI) categories or have combined weight groups in comparisons 4, 7, 11, 12, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . Comparability of available studies is therefore limited and this in turn impedes meta-analyses. Generally speaking, most studies that have used WHO categories reported a trend towards improved mortality in obese patients 5, 6, 13, 26 , whereas those that combined WHO categories have tended to report none 14, 15, 17 .
Obesity has been estimated to cost our healthcare system $14.5 billion annually 27 and is associated with greater prevalence and severity of coronary artery disease 28 . Morbidly obese patients undergoing cardiothoracic surgery, in particular, have been shown to require considerably more resource utilisation, with lengthier ICU stays and operating times. At approximately $5750 per ICU day and $64 per operative minute 29 , these financial implications are not insignificant. In the current era of healthcare reform and global economic recession, knowing the prevalence of obesity and its possible effect on our ICUs is thus of great public health importance. We hypothesised that obesity, defined as a BMI greater than 30 kg/m 2 , has increased in prevalence and, in turn, has increased our incidence of morbidity in the cardiothoracic population.
of the Declaration of Helsinki and approved by a fully constituted Human Research and Ethics Committee (Approval No.: QA2014109). We undertook a retrospective review of data retrieved from the cardiothoracic surgery department repository of a single university-affiliated tertiary teaching hospital in metropolitan Melbourne, Victoria. Data from this site is contributed to the Australian and New Zealand Society of Cardiac and Thoracic Surgeons National Cardiac Surgery Database Program. Data are collected prospectively for all patients who meet database entry criteria as follows: (i) patients undergoing cardiac surgery, (ii) thoracic surgery requiring cardiopulmonary bypass or (iii) pericardiectomy for constrictive pericarditis, performed on or off cardiopulmonary bypass. Preoperative data are collected by resident medical officers, intraoperative data by the operating surgeon and postoperative data by the associated registrar. Data on 30-day mortality and rates of readmission are collected and, at this site, all data are verified by a dedicated data manager. The National Cardiac Surgery Database Program administrators undertake biannual audits of a proportion of randomly selected patients from contributing sites for quality-control purposes to ensure data integrity. Deaths outside the hospital in the first 30 days are initially verified by confirmation with the treating surgeon, cardiologist, or general practitioner, then further confirmed with the National Death Index.
Setting and participants
The setting for this study was the Royal Melbourne Hospital, a centre that serves a population base of more than 1 million and provides over 100,000 episodes of care each year. Annually, there are approximately 850 cardiothoracic procedures performed at this site. Data analysed included preoperative patient demographics, risk factors for coronary artery disease and operative characteristics with variables defined according to the National Cardiac Surgery Database Program. Mortality was defined as death in the first 30 days after operation. Morbidity outcomes were new postoperative complications defined as follows: • prolonged mechanical ventilation >24 hours • reintubation • pneumonia diagnosed by positive culture of sputum or tracheal aspirate and consistent with clinical findings of pneumonia (including radiological changes) • return to theatre for any cause and return to theatre for bleeding • renal failure that did not exist preoperatively that required at least two of the following: raised serum creatinine level >200 µmol/l, doubling or greater of preoperative creatinine level and a requirement for dialysis or haemofiltration • deep sternal wound infection involving muscle and bone, with or without mediastinal infection, as demonstrated by surgical exploration requiring wound debridement and one of the following; positive cultures or treatment with antibiotics • stroke, defined as a new central neurological deficit that persists for more than 72 hours • perioperative acute myocardial infarction diagnosed by two of the following three criteria: a) enzyme level elevation, provided operation does not involve myocardial incision, b) new wall motion abnormalities, c) serial electrocardiogram (at least two) showing new Q waves, in two contiguous leads • readmission to the ICU after transfer to a high-dependency unit or ward • length of stay in the ICU, and • prolonged length of postoperative stay (>14 days).
Main outcome measures

Statistical analysis
All data were analysed using IBM SPSS Statistics Version 22 (IMB Corp., Armonk, NY, USA). Continuous variables are presented as mean (M) and standard deviation (SD) if normally distributed or median (Med) and quartiles (Q1, Q3) if not. Frequencies (n) and proportions (%) were calculated for categorical variables. All data were screened for missing and abnormal values prior to completing descriptive univariate analyses. We used t-tests, Mann-Whitney U, analysis of variance or Kruskal-Wallis to compare continuous variables, the chi-square (χ 2 ) test for assessment of categorical variable association and eta squared for assessment of effect size.
Our approach to multivariate logistic regression analysis mirrored that described by Yap et al 19 in order to examine the effect of obesity on morbidity and mortality. We adjusted for the following confounders: age, sex, diabetes, hypercholesterolaemia, hypertension, renal failure, cerebrovascular disease, peripheral vascular disease, lung disease, heart failure (New York Heart Association Class IV), severe left ventricular impairment (ejection fraction <30%), infective endocarditis, emergency or salvage status, previous cardiac intervention, operation other than isolated coronary artery bypass grafting, and total cardiopulmonary bypass time. All tests were two-tailed and a P-value of 0.05 was considered statistically significant.
Results
From 1 January 2002 to 31 December 2014, 8140 patients met the Australian and New Zealand Society of Cardiac and Thoracic Surgeons database entry criteria. Of these, 8064 met our entry criteria. Patients included in this analysis were aged 18 years or older, required an admission to the ICU for immediate postoperative management and had no missing data for outcome measures (n=8064, 99.1%).
Mean BMI of the cohort was 28.5 ± 5.3 kg/m 2 . Eighty (1.0%) patients were classified as underweight and 1910 (23.7%) patients were within the normal weight range. The majority of patients were overweight (n=3371, 41.8%) and 33.5% (n=2703) were obese. Within the group of obese patients, most were moderately obese (n=1864, 23.1%; BMI 30.0 to 34.99), followed by severely obese (n=589, 7.3%) and lastly, morbidly obese (n=250, 3.1%).
Mean BMI varied very little between year of surgery (n=0.003), with the mean BMI in 2012 (29.1 ± 6.2) differing little from 2009 (28.0 ± 4.9) and 2005 (28.0 ± 4.8) ( Figure 1 ).
The prevalence of patients considered obese was relatively constant from 2002 to 2014, as shown in Figure 2 (χ 2 [12] 19.8, P=0.07). However, there was a clear trend towards an increased proportion of morbidly obese patients, shown in Figure 3 (χ 2 [12] 45.4, P <0.001).
The mean age of the cohort was 64.9 ± 13.2 years. Underweight patients (n=80, 1.0%) were younger (57.6 ± 20.6 years) than those not underweight (65.0 ± 13.1 years; t (8062)=5.0, P <0.001). Underweight patients were more commonly female (n=45, 56.3%) and undergoing elective surgery (n=57, 71.3%), such as coronary artery bypass grafting (n=30, 37.5%), valvular intervention associated with coronary artery bypass grafting (n=11, 13.7%), or valve and other cardiac surgery (n=39, 48.8%) combined. In the remainder of the cohort, weight increased as age decreased. This trend can be seen in Figure 4 . Post hoc comparisons using the Tukey honest significant difference test indicated morbidly obese patients were on average younger (62.4 ± 12.2 years) than those who were severely obese (63.6 ± 11.8 years), moderately obese (65.0 ± 11.5 years) or overweight (65.9 ± 12.3 years; F [3, 6073]=11.9, P <0.001; effect size calculated using eta squared was 0.005), as shown in Figure  4 . Demographic, preoperative and operative characteristics for categories of normal (n=1910), obese (n=2703) and morbidly obese (n=250) patients are shown in Table 1 .
Essentially, when compared to patients within the normal weight range, obese patients were younger, diabetic, with high cholesterol, hypertension, and severe shortness of breath (New York Heart Association Class IV), and were undergoing elective isolated coronary artery bypass grafting surgery. Morbidly obese patients were younger again and more likely to be females in whom diabetes, high cholesterol, hypertension, and severe shortness of breath prevailed. This could suggest that there is an association with a younger age at presentation for coronary artery bypass grafting in the obese and morbidly obese patients in our cohort. 28.00
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28.80 29.00 29.20 Year of surgery Mean BMI Procedural variations were not significantly different between patients within the normal weight range and morbidly obese patients. However, postoperative outcomes did differ (Table 2 ). Prior to adjusting for confounders, both obesity and morbid obesity were associated with newonset renal failure and deep sternal wound infection, but lower odds of return to theatre. However, obesity was also associated with reduced 30-day mortality, whereas morbid obesity was also associated with longer postoperative stay, longer mechanical ventilation, and higher odds of ICU readmission and reintubation.
Direct-entry logistic regression was used to assess the impact of demographics and other potential confounders on outcomes associated with obesity. Two models were used that could distinguish between 1) normal weight and obese patients (χ 2 [28, n=4,613]=487.3, P <0.001) and 2) normal weight and morbidly obese patients (χ 2 [28, n=2,160]=291.7, P <0.001). The first model explained 14.5% (Nagelkerke R2) of variation in obesity and correctly classified 65.4% of cases. The second explained 26.2% (Nagelkerke R2) of variation in obesity and correctly classified 88.9% of cases.
After adjusting for potential confounders with these models, both obesity and morbid obesity continued to be associated with new-onset renal failure (adjusted OR 1.62, 95% CI 1.26 to 2.08, P <0.001, and adjusted OR 3.17, 95% CI 1.96 to 5.13, P <0.001, respectively) and lower odds of return to theatre (adjusted OR 1.62, 95% CI 1.26 to 2.08, P <0.001, and adjusted OR 0.20, 95% CI 0.05 to 0.86, P=0.03, respectively). However, the association with deep sternal wound infection was no longer statistically significant.
Obesity remained associated with decreased 30-day mortality (adjusted OR 0.41, 95% CI 0.24 to 0.74, P=0.003).
Unlike obesity, morbid obesity was not associated with decreased 30-day mortality (adjusted OR 0.34, 95% CI 0.09 to 1.30, P=0.115). It remained associated with length of stay over 14 days (adjusted OR 2.05, 95% CI 1.26 to 3.33, P=0.004). However, its association with longer mechanical ventilation, ICU re-admission and reintubation were no longer statistically significant.
Discussion
This is the first study to examine the prevalence and outcomes of obesity in cardiothoracic ICU patients in a single centre since 2007, specific to cardiothoracic patients and over such an extended time period. Contrary to our expectation, the rise in national prevalence of obesity from 16.3% to 27.2% 1, 30 was not mirrored by an increase in the prevalence of obese cardiothoracic patients in the Royal Melbourne Hospital ICU. Instead, between 2002 and 2014, the prevalence of obesity remained relatively constant at around 33.5%. However, this is higher than the 30.4% prevalence previously reported in 2007 4 . Our annual increase in mean BMI (28.0 in 2005 versus 29.1 in 2012) is also slightly higher than that reported by the largest observational database in this area to date 13 , although this study excluded cardiothoracic surgery patients. We also observed an increase in morbid obesity despite a stable overall obese demographic across the same time period. Our results suggest that morbid obesity is a growing problem in younger patients requiring cardiac surgery for coronary artery disease, which places a great burden on resource use in the ICU. Many of the comorbidities associated with obesity complicate ICU care, such as increased risk of myocardial infarction, type 2 diabetes mellitus and obstructive sleep apnoea 31, 32 . In addition, procedures performed in the ICU such as line insertion, intubation, mechanical ventilation, imaging and pharmacokinetic dosing are more complicated in obese patients. Obesity also presents technical challenges to the cardiac surgeon 33 . Poor operative exposure of the heart, operating at depth within the chest, poor internal mammary artery exposure during harvest, problems with harvesting the long saphenous vein, and obtaining good lower limb wound closure are just several of these. Despite these complications, our results support international studies of general ICU patients that have found that when obese patients are admitted to the ICU, their obesity protects against mortality, a phenomenon known as the 'obesity paradox' 6, 13, 26 . However, while obese patients supported the obesity paradox, morbidly obese patients did not. This outcome has been previously reported by an ICU meta-analysis of the obesity paradox 5 .
Other ICU studies of cardiothoracic patients have demonstrated no difference in mortality for obese cardiothoracic patients 4, 14, 15 . An explanation for this may be that many prior studies did not compare outcomes based on standard WHO BMI categories, or combined all other weight groups as a comparison 11, 14, 17 . Given that this study and others have shown a U-shaped relationship between BMI and patient outcomes, with worse outcomes for both underweight (BMI <18.5 kg/m 2 ) or morbidly obese (>40 kg/m 2 ) patients 13 , inclusion of underweight patients in the reference group and morbidly obese patients in the obese group might conceivably bias the result. Supporting this, studies such as ours that used categories similar to the WHO BMI or that ran meta-analyses tended to support the obesity paradox [11] [12] [13] .
Several theories attempt to explain the obesity paradox. A popular explanation is that having greater metabolic reserves protects against hypercatabolism in acute illness 34 . Alternatively, evidence suggests that obesity confers immunological benefits in acute illness, such as a blunted host inflammatory response in septic shock 35 , higher levels of anti-inflammatory cytokines 36 , higher levels of helpful macrophages, and lower adiponectin levels 37 . Another theory proposes that obese individuals benefit from the association between lower adiponectin levels and a protective pro-inflammatory response in the initial phase of illness 38 . Management of fluids in the ICU may also explain the obesity paradox; obese patients tend to receive less fluid resuscitation per kilogram, and studies have shown that overresuscitation may have detrimental effects 39 .
Then again, obese patients in the ICU may just be less sick. Proponents of this explanation criticise the inability of the Simplified Acute Physiology Score II to distinguish chronic disease from acute illness. That is, chronic disease is more common in obese patients and their Simplified Acute Physiology Score II may be higher due to chronic rather than acute illness. Thus, obese patients may have less severe disease than perceived, resulting in a seemingly better mortality when comparing obese patients against normal patients with the same Simplified Acute Physiology Score II. Another scoring system used in a number of studies in the literature, Acute Physiology and Chronic Health Evaluation II, is also not validated in morbidly obese patients 40 . Obese patients might also be initially less sick because of selection bias, that is, surgeons are less likely to operate on obese, elderly patients with multiple comorbidities and as a result, most of the obese cardiothoracic patients in ICU are younger and fitter than the more elderly patients at a normal weight. This is reflected in the demographics of our study population. Additionally, obese patients may have a lower threshold for ICU admission or be admitted to the ICU for reasons not related to acute illness, such as greater nursing needs 41 . Since all cardiac surgical patients are admitted to the ICU postoperatively, this does not in isolation explain the findings of our study.
Our study found that obesity and morbid obesity were associated with decreased return to theatre for bleeding. This association has been previously documented 25 . The mechanism is unclear, but studies have shown that obesity may predispose to hypercoagulability 42 , particularly after injury 43 . Alternatively, the authors propose that surgeons may just be more reluctant to take these patients back because of perceived risk or technical difficulty. For example, perhaps the drain-output threshold for a return to theatre decision may be adjusted in these patients.
While obesity may be associated with improved survival, the majority of ICU studies have also reported an association between obesity and increased morbidity. We found an association between morbid obesity and increased length of stay longer than 14 days. We also found an association between new-onset renal failure and both obesity and morbid obesity. Both these findings are consistent with a previous Australian study by Yap et al 4 . While the reasons behind the lengthier stays of morbidly obese patients are unclear, they are of great concern, given the significant financial burden they generate for the ICU department 29 . The association with new-onset renal failure may be due to a predisposition for poorer renal function, given the higher likelihood of hypertension and diabetes among our obese patients, which the physiological stress of cardiothoracic surgery may further exacerbate. Unlike numerous other studies, we did not find a significant association with deep sternal wound infection, or mechanical ventilation. By comparison, Yap et al found an increased risk of deep sternal wound infection, prolonged ventilation, and re-admission to ICU 4 . This discrepancy may be explained by improvements in intensive care protocols and technology since this previous paper was published and is encouraging. That said, there is inconsistency in associated morbidity, even among more recent and highly powered studies (n >50,000 patients) 6, 13, 26 . This may be because height and weight were estimated in most trials and errors can lead to BMI group misallocations with prognostic impact of unpredictable magnitude and direction across studies.
Limitations
There are several potential limitations of our study. BMI is not an ideal way of measuring obesity; it does not account for muscle bulk and also relies on measuring device consistency. However, accurately measuring percentage body fat content requires sophisticated imaging techniques. Secondly, we were unable to adjust for chronic and/or acute fluid-related weight changes. Thirdly, our study was a retrospective and single-centre study that investigated a specific subgroup of surgical ICU patients and, as such, the results may not be generalisable to the overall ICU population. Lastly, our study only assessed postoperative complications occurring within 30 days of surgery, which may miss later complications.
The strengths of our study were a large sample size and the use of WHO BMI categories to facilitate interpretation. Our dataset collection spanned over a decade and is strengthened by its completeness, with all cardiothoracic patients included across the period. The data examined is also the most up-todate, being the first in the Australian setting in almost ten years, and covering a period of time when obesity rates have dramatically increased at the population level.
Conclusions
Obesity among ICU cardiothoracic patients in our institution has remained stable over the past decade, though at a prevalence greater than that of the general adult population.
A key finding of this study, however, is that a growing proportion of our obese ICU patients are morbidly obese, with a dramatically increased length of ICU stay. This has major implications for resource allocation in the ICU, and may inform modelling of future bed utilisation. Our study also mirrors international data, with obesity (although not morbid obesity) conferring a mortality benefit in our population. Better understanding of the reasons for lengthier stays in morbidly obese patients should be a focus of further research in this area.
